본문 바로가기
KERD
논문KCI 등재

C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류치의학

초록

Objectives: Many studies have examined histopathological factors and various prognostic scores related to inflammation to predict outcomes. Here, we examined the prognostic value of the C-reactive protein/albumin (CRP/alb) ratio in oral squamous cell carcinoma (OSCC).Materials and Methods: This retrospective study included 40 patients with OSCC. Using univariate and multivariate analyses, we focused on the correlation of the CRP/alb ratio with clinicopathological characteristics and with overall survival. We then compared five inflammation-based prog-nostic scores, CRP/alb ratio, modified Glasgow Prognostic Score (mGPS), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and prognostic nutritional index (PNI), based on receiver operating characteristic (ROC) curves.Results: The optimal cut-off value for the CRP/alb ratio was 0.085. The group with a high CRP/alb ratio had a high TNM clinical stage (P=0.002) and larger primary tumors (P=0.029), with statistically significant differences in lymph node metastasis and distant metastasis. In addition, when the CRP/alb ratio was high, multivariate analysis showed a lower survival rate (P=0.002; hazard ratio=6.078), and the ROC curve showed more outstanding dis-criminatory ability regarding overall survival compared to other inflammation-based prognostic scores.Conclusion: The CRP/alb ratio can be an independent prognostic factor when predicting prognosis in OSCC and has good prognostic ability.

Abstract

Objectives: Many studies have examined histopathological factors and various prognostic scores related to inflammation to predict outcomes. Here, we examined the prognostic value of the C-reactive protein/albumin (CRP/alb) ratio in oral squamous cell carcinoma (OSCC).Materials and Methods: This retrospective study included 40 patients with OSCC. Using univariate and multivariate analyses, we focused on the correlation of the CRP/alb ratio with clinicopathological characteristics and with overall survival. We then compared five inflammation-based prog-nostic scores, CRP/alb ratio, modified Glasgow Prognostic Score (mGPS), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and prognostic nutritional index (PNI), based on receiver operating characteristic (ROC) curves.Results: The optimal cut-off value for the CRP/alb ratio was 0.085. The group with a high CRP/alb ratio had a high TNM clinical stage (P=0.002) and larger primary tumors (P=0.029), with statistically significant differences in lymph node metastasis and distant metastasis. In addition, when the CRP/alb ratio was high, multivariate analysis showed a lower survival rate (P=0.002; hazard ratio=6.078), and the ROC curve showed more outstanding dis-criminatory ability regarding overall survival compared to other inflammation-based prognostic scores.Conclusion: The CRP/alb ratio can be an independent prognostic factor when predicting prognosis in OSCC and has good prognostic ability.

참고문헌 (46)

  1. Ju Rim Sun, "Oral cancer incidence based on annual cancer statistics in Korea", 대한구강악안면외과학회지, 38(1), pp.20~28 (2012), 대한구강악안면외과학회
  2. Lo Muzio L, "Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis", Minerva Stomatol, 56, pp.341~347 (2007)
  3. Spencer KR, "Current concepts in the management of oral squamous cell carcinoma", Aust Dent J, 47, pp.284~289 (2002)
  4. Klug C, "Preoperative chemoradiotherapy in the management of oral cancer: a review", J Craniomaxillofac Surg, 36, pp.75~88 (2008)
  5. Genden EM, "Contemporary management of cancer of the oral cavity", Eur Arch Otorhinolaryngol, 267, pp.1001~1017 (2010)
  6. 금동호, "The impact factors on 5-year survival rate in patients operated with oral cancer", 대한구강악안면외과학회지, 39(5), pp.207~216 (2013), 대한구강악안면외과학회
  7. Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)
  8. Sun K, "The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis", J Cancer Res Clin Oncol, 140, pp.1537~1549 (2014)
  9. Paramanathan A, "A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours", Surg Oncol, 23, pp.31~39 (2014)
  10. Gomez D, "Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma", World J Surg, 32, pp.1757~1762 (2008)
  11. Pinato DJ, "A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma:the prognostic nutritional index (PNI)", Br J Cancer, 106, pp.1439~1445 (2012)
  12. Liu H, "Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer", J Thorac Dis, 5, pp.783~789 (2013)
  13. Khandavilli SD, "Serum Creactive protein as a prognostic indicator in patients with oral squamous cell carcinoma", Oral Oncol, 45, pp.912~914 (2009)
  14. Jin Y, "Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer", Clinics (Sao Paulo), 68, pp.686~693 (2013)
  15. Liu X, "Preoperative C-reactive protein", albumin ratio predicts prognosis of patients after curative resection for gastric cancer, 2015, pp.8, 339~345
  16. Zhou T, "Ratio of Creactive protein", albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer, 2015, pp.5, 10481~
  17. Wei XL, "A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein", albumin ratio, 2015, pp.15, 350~
  18. Kinoshita A, "The C-reactive protein", albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma, 2015, pp.22, 803~810
  19. Edge SB, "The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
  20. Budczies J, "Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization", PLoS One, 7, pp.e51862~ (2012)
  21. Diakos CI, "Cancerrelated inflammation and treatment effectiveness", Lancet Oncol, 15, pp.e493~503 (2014)
  22. Hanahan D, "Hallmarks of cancer: the next generation", Cell, 144, pp.646~674 (2011)
  23. Balkwill F, "Inflammation and cancer: back to Virchow?", Lancet, 357, pp.539~545 (2001)
  24. Allavena P, "Chemokines in cancer related inflammation", Exp Cell Res, 317, pp.664~673 (2011)
  25. Castell JV, "Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6", Hepatology, 12, pp.1179~1186 (1990)
  26. Gallo O, "Interleukin-6 and acute-phase proteins in head and neck cancer", Eur Arch Otorhinolaryngol, 252, pp.159~162 (1995)
  27. Pepys MB, "C-reactive protein: a critical update", J Clin Invest, 111, pp.1805~1812 (2003)
  28. Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
  29. Nozoe T, "Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma", Am J Surg, 182, pp.197~201 (2001)
  30. Gockel I, "Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus", World J Gastroenterol, 12, pp.3746~3750 (2006)
  31. von Meyenfeldt M, "Cancer-associated malnutrition: an introduction", Eur J Oncol Nurs, 9(Suppl 2), pp.S35~38 (2005)
  32. Gupta D, "Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature", Nutr J, 9, pp.69~ (2010)
  33. Alberici Pastore C, "Association between an inflammatory-nutritional index and nutritional status in cancer patients", Nutr Hosp, 28, pp.188~193 (2013)
  34. Roxburgh CS, "Cancer and systemic inflammation:treat the tumour and treat the host", Br J Cancer, 110, pp.1409~1412 (2014)
  35. Metgud R, "Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy", Biotech Histochem, 89, pp.8~13 (2014)
  36. Rachidi S, "Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma", Head Neck, 38(Suppl 1), pp.E1068~1074 (2016)
  37. Farhan-Alanie OM, "Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma", Br J Oral Maxillofac Surg, 53, pp.126~131 (2015)
  38. Fang HY, "Refining the role of preoperative C-reactive protein by neutrophil", lymphocyte ratio in oral cavity squamous cell carcinoma, 2013, pp.123, 2690~2699
  39. Fairclough E, "Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein", albumin ratio as a predictor of patient outcome, 2009, pp.9, 30~33
  40. Ranzani OT, "Creactive protein", albumin ratio predicts 90-day mortality of septic patients, 2013, pp.8, e59321~
  41. Xu XL, "A novel inflammationbased prognostic score, the C-reactive protein", albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma, 2015, pp.10, e0138657~
  42. Proctor MJ, "Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study", Cancer, 119, pp.2325~2332 (2013)
  43. Proctor MJ, "An inflammation-based prognostic score (mGPS)predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study", Br J Cancer, 104, pp.726~734 (2011)
  44. Shafique K, "The modified Glasgow prognostic score in prostate cancer:results from a retrospective clinical series of 744 patients", BMC Cancer, 13, pp.292~ (2013)
  45. Zhou T, "A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer", Tumour Biol, 36, pp.337~343 (2015)
  46. McMillan DC, "The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer", Cancer Treat Rev, 39, pp.534~540 (2013)

관련 논문AI추천

Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma김문영, 김철환, 박성민, 박재우, 하용찬대한구강악안면외과학회 · 대한구강악안면외과학회지2017 · 제43권 제5호Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic CancerBo-Jun Wang, Chang-Jie Lou, Chao Liu, Chun-Hui Zhang, Dan Wang, Fei-Hu Yan, Jia-Ni Yang, Jie Lian, Jing Chen, Lin Fang, Rui-Yang Li, Shu-Ling Han, Yang Yao, Yan-Qiao Zhang, Yi-Bing Bai, Zhi-Wei Li대한암학회 · Cancer Research and Treatment2021 · 제53권 제1호두경부 암 환자에서 수술 전 호중구-림프구 비율의 임상적 효용성강준명, 강하람, 김근전, 서재현, 윤호영, 이현호, 주영훈, 진호준, 황세환대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2020 · 제63권 제1호Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapyDae Sik Kim, Eun Joo Kang, Hong Jun Kim, Jae Hong Seo, Jung Sun Kim, Jun Suk Kim, Sang Cheul Oh, Suk-young Lee, Yoon Ji Choi대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제1호The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with ChemoradiotherapyByung Min Lee, Jee Suk Chang, Jinsil Seong, Kyong Joo Lee, Seung Yeun Chung거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제3호Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyChao-Feng Li, Chao-Nan Qian, Dong-Hua Luo, Hai-Qiang Mai, Hao-Yuan Mo, Ka-Jia Cao, Ling Guo, Lin-Quan Tang, Li-Ting Liu, Ming-Yuan Chen, Qing-Nan Tang, Qiu-Yan Chen, Rui Sun, Shan-Shan Guo, Wen-Hui Chen, Xiang Guo, Xue-Song Sun, Yang Li, Yan He, Yu-Jing Liang, Yu-Ying Fan대한암학회 · Cancer Research and Treatment2018 · 제50권 제3호

이 간행물의 다른 논문 (13건)